Dronedarone in high-risk permanent atrial fibrillation.
Connolly SJ; Camm AJ; Halperin JL; Joyner C; Alings M; Amerena J; Atar D; Avezum Á; Blomström P; Borggrefe M; Budaj A; Chen SA; Ching CK; Commerford P; Dans A; Davy JM; Delacrétaz E; Di Pasquale G; Diaz R; Dorian P; Flaker G; Golitsyn S; Gonzalez-Hermosillo A; Granger CB; Heidbüchel H; Kautzner J; Kim JS; Lanas F; Lewis BS; Merino JL; Morillo C; Murin J; Narasimhan C; Paolasso E; Parkhomenko A; Peters NS; Sim KH; Stiles MK; Tanomsup S; Toivonen L; Tomcsányi J; Torp-Pedersen C; Tse HF; Vardas P; Vinereanu D; Xavier D; Zhu J; Zhu JR; Baret-Cormel L; Weinling E; Staiger C; Yusuf S; Chrolavicius S; Afzal R; Hohnloser SH; The New England Journal Of Medicine, 2011, vol. 365, issue 24, p 2268, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation